FILE - In this March 2020 photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. (Gilead Sciences via AP)

Health Canada approves remdesivir for treatment of severe COVID-19

First drug authorized by the agency to treat the virus

Health Canada has authorized the use of drug remdesivir to treat severe symptoms of COVID-19, the agency said Tuesday (July 28).

The antiviral drug, manufactured by Gilead Sciences Canada, Inc., is the first treatment authorized for patients with serious symptoms of the virus in Canada. The drug is currently only approved for use in adults and teens aged 12 and up with a weight of at least 40 kilograms. It is not authorized for use in children or pregnant women, and is administered intravenously to treat patients with pneumonia requiring supplemental oxygen.

Canada is not the first to approve the use of remdesivir for COVID-19; the drug has been approved for use in U.S., Europe, Japan, Singapore and Australia. So far, the agency said a “small number” of patients are being treated with the drug under the Special Access Program, which will not be required for new patients going forward.

Health Canada said it completed an expedited six-week review to determine the drug’s benefits outweigh its risks when it comes to COVID-19. Two existing clinical trials are ongoing to evaluate the safety and efficacy of remdesivir. According to the European Medicines Agency, the most common side effect in healthy volunteers are increased blood levels of liver enzymes, and nausea in COVID-19 patients.

ALSO READ: B.C. sets limits on number of guests, visitors in vacation rentals, houseboats

ALSO READ: B.C. records 81 more cases of COVID-19 in B.C. in three days


@katslepian

katya.slepian@bpdigital.ca

Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirus

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

‘Best of Cloverdale’ contest returns

Voters can cast ballots once a day until Sept. 5; enter to win $250 gift card for Save-On-Foods

Surrey Police Board approves creation of municipal force at first-ever meeting

Process for hiring a police chief to ‘start immediately’: McCallum

Delta Nature Reserve boardwalk realignment to begin this fall

Stretch of boardwalk to be rebuilt to make room for new Highway 91/Nordel Way vehicle ramp

Cloverdale store owner giving away free face shields

Tricia Ellingsen offering more than 200 free protective shields

Illegal suite a concern for Cloverdale man

Despite a City-issued stop-work order, construction continues

371 British Columbians battling COVID-19, health officials confirm

Thursday (Aug. 6) saw a second straight day of nearly 50 new confirmed cases

Four activists face charges linked to 2019 Abbotsford hog-farm protest

Mischief and break-and-enter charges laid for incidents on four separate days prior to the protest

Visitors and non-residents entering closed remote B.C. First Nation’s territories

With limited resources, they say they don’t have any authority or power to enforce the closures

UBC loses appeal on Fisheries Act convictions

BC Supreme Court upholds order to pay $1.55-million fine

Masks to be mandatory on BC Transit, TransLink starting Aug. 24

Both BC Transit and TransLink made the announcement in separate press releases on Thursday

‘Tiny home’ being built for Abbotsford woman with severe allergies

Online campaign raises $59,000 for custom cargo trailer for Katie Hobson

Acclaimed B.C. actor Brent Carver passes away

Carver, one of Canada’s greatest actors with a career spanning 40 years, passed away at home in Cranbrook

B.C. would not send students back to school if there was ‘overwhelming risk’: Horgan

Plan has left many parents across the province worried about their children’s safety

Most Read